As consequence, the altered expression of PPARα can significantly affect fatty acid oxidation and induce lipogenesis, resulting in an increase in fatty acid production, one of the factors for the progression of NASH. The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatohepatitis.